Wedbush analyst Andreas Argyrides downgrades Global Blood Therapeutics (NASDAQ:GBT) from Outperform to Neutral.
Reported Late Wednesday, ICL Invests €2.75M In Breakthrough Sustainable Protein Ingredients Startup Arkeon, GmbH; Companies Partnering To Develop CO2-Derived Protein Ingredients For Food Applications, Using Arkeon’s Carbon Conversion Process
Companies partnering to develop CO2-derived protein ingredients for food applications, using Arkeon's carbon conversion process
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today
